Drug Database
Back to search

Netherlands· NL-dcd8e70c3011

Toxogonin, ampullen 250 mg/ml

A obidoxime product containing obidoxim dichloride, registered in Netherlands by SERB S.A.. The same ATC class is registered in 5 of our 19 countries.

ATC V03AB13

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedToxogonin, ampullen 250 mg/mlATCV03AB13REGISTER NO.NL-dcd8e70c3011PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about obidoxim dichlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Obidoxime is registered in 5 of 19 countries.

Countries holding a registration under ATC V03AB13 (obidoxime), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search obidoxime products by name

Obidoxime · ATC V03AB13

5 / 19 countries

  • Czechiaprice
  • Germany
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
OBIDOXIM DICHLORIDE
Manufacturer
SERB S.A.
Country
Netherlands (NL)
ATC code
V03AB13
ATC class
Obidoxime
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    04562

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V03AB13

Obidoxime, as other registers publish it.

All obidoxime products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd8b14ac-1726-4882-9ce6-4400a992070c
GET /v1/drugs/dd8b14ac-1726-4882-9ce6-4400a992070c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": null,
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h04562_smpc.pdf",
  "strength": null,
  "atc_label": "Obidoxime",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg04562",
  "excipients": [
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "OBIDOXIM DICHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h04562.pdf",
  "authorised_at": "1965/05/04",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "04562",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about obidoxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console